Angiotensin II B-type receptor mediates phosphoinositide hydrolysis in mesangial cells.
Pfeilschifter
J
J
Research Department, Pharmaceuticals Division, Ciba-Geigy Ltd., Basel, Switzerland.
D000804:Angiotensin II / Q000037:antagonists & inhibitors / Q000378:metabolism* / Q000494:pharmacology; D057911:Angiotensin Receptor Antagonists; D000818:Animals; D001713:Biphenyl Compounds / Q000494:pharmacology; D002478:Cells, Cultured; D005920:Glomerular Mesangium / Q000166:cytology / Q000378:metabolism*; D006868:Hydrolysis; D007093:Imidazoles / Q000494:pharmacology; D015544:Inositol 1,4,5-Trisphosphate / Q000378:metabolism; D019808:Losartan; D009842:Oligopeptides / Q000494:pharmacology; D010716:Phosphatidylinositols / Q000378:metabolism*; D051381:Rats; D011945:Receptors, Angiotensin / Q000502:physiology*; D013268:Stimulation, Chemical
D057911:Angiotensin Receptor Antagonists; D001713:Biphenyl Compounds; D007093:Imidazoles; D009842:Oligopeptides; D010716:Phosphatidylinositols; D011945:Receptors, Angiotensin; D000804:Angiotensin II; C060894:CGP 42112A; D015544:Inositol 1,4,5-Trisphosphate; D019808:Losartan